D. Boral Capital Upgrades CervoMed (NASDAQ:CRVO) to “Buy”
CervoMed (NASDAQ:CRVO – Get Free Report) was upgraded by equities research analysts at D. Boral Capital from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a $10.00 price objective on the stock. D. Boral Capital’s target price points to a […]
CervoMed (NASDAQ:CRVO – Get Free Report) was upgraded by equities research analysts at D. Boral Capital from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm currently has a $10.00 price objective on the stock. D. Boral Capital’s target price points to a […]
